Mevion Medical Systems
RELATED CONTENT
Mevion Medical Systems announced a strategic agreement with medPhoton GmbH to integrate ImagingRing, an innovative cone beam computed tomography (CBCT) system for volumetric image guidance, with the Mevion S250i with Hyperscan, Mevion’s pencil-beam scanning proton therapy system. The new CBCT offering will debut at the 36th annual meeting of the European Society for Radiotherapy & Oncology (ESTRO), May 5-9 in Vienna, Austria.
May 04, 2017 
April 4, 2017 — Mevion Medical Systems announced the installation of the first Mevion S250i proton therapy system with ...
April 04, 2017 
Mevion Medical Systems and UF Health Cancer Center - Orlando Health recently announced the first patient treatment on a Mevion S250 proton therapy system in conjunction with Airo, a mobile, diagnostic computed tomography (CT) scanner. The advanced 3D CT-based localization is integrated to Verity Patient Positioning System, a component of the Mevion S250 Series, and is based on high-precision stereotactic localization and tracking technology. This solution improves treatment accuracy and reduces patient positioning uncertainties.
January 27, 2017 
RaySearch and Mevion Medical Systems are extending their collaboration agreement to support the RayCare oncology information system (OIS), currently in development at RaySearch, and to take full advantage of the advanced treatment capabilities of the Mevion S250i with Hyperscan and Adaptive Aperture. The agreement was announced at the 58th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston.
September 26, 2016 
Mevion Medical Systems announced that it will be installing its Mevion S250i proton therapy system at the Zuidoost Nederland Protonen Therapie Centrum, BV (ZON-PTC) in the Netherlands. The system delivers high-quality adaptive intensity modulated proton therapy (IMPT) with Mevion’s Hyperscan pencil beam scanning and Adaptive Aperture technology.
September 23, 2016 
Mevion Medical Systems will showcase its pencil beam scanning Hyperscan with Adaptive Aperture at the 2016 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 25-28 in Boston. The advanced proton micro-multileaf collimator (mMLC) technology is integrated into the Mevion S250i with Hyperscan, making pencil beam scanning sharper and faster and delivering robust intensity modulated proton therapy (IMPT).
September 22, 2016 
The global proton therapy market hit a major milestone in 2015, eclipsing the billion-dollar mark for sales orders and more than doubling the previous year’s total, according to market intelligence firm Medraysintell. This boom was evidenced by new proton therapy centers springing up all over the world, including 11 just since November 2015 — eight in the United States and three abroad in Hong Kong, Belgium and the Netherlands.
September 07, 2016 
Mevion Medical Systems announced that University Hospitals (UH) in Cleveland used the Mevion S250 proton therapy system to treat its first patient, a 24-year-old woman with rhabdomyosarcoma, a rare form of sarcoma.
July 29, 2016 
University Hospitals in Cleveland recently held a ceremony to mark the completion of its new $30 million proton therapy center, the first in the state of Ohio.
June 02, 2016 
Physicians have begun treating patients with the Mevion S250 proton therapy system at The Marjorie and Leonard Williams Center for Proton Therapy at UF Health Cancer Center-Orlando Health in Florida.
April 13, 2016